BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30444134)

  • 1. How our understanding of the microbiome has changed the way we look at liver diseases.
    Adolph TE; Effenberger M; Tilg H
    Biomark Med; 2018 Nov; 12(11):1203-1206. PubMed ID: 30444134
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-Microbiome Axis in Health and Disease.
    Adolph TE; Grander C; Moschen AR; Tilg H
    Trends Immunol; 2018 Sep; 39(9):712-723. PubMed ID: 29843959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
    Jiang L; Schnabl B
    Physiology (Bethesda); 2020 Jul; 35(4):261-274. PubMed ID: 32490750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intestinal microbiome and paediatric liver disease.
    Leung DH; Yimlamai D
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):446-455. PubMed ID: 28497760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outside the liver box: The gut microbiota as pivotal modulator of liver diseases.
    Wahlström A
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):912-919. PubMed ID: 31007175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Liver Injury (II): Chronic Liver Injury.
    Baker SS; Baker RD
    Adv Exp Med Biol; 2020; 1238():39-54. PubMed ID: 32323179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota and the liver.
    Shen TD; Pyrsopoulos N; Rustgi VK
    Liver Transpl; 2018 Apr; 24(4):539-550. PubMed ID: 29316191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome and liver disease.
    Betrapally NS; Gillevet PM; Bajaj JS
    Transl Res; 2017 Jan; 179():49-59. PubMed ID: 27477080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of γδT cells in liver diseases and its relationship with intestinal microbiota.
    Zhou QH; Wu FT; Pang LT; Zhang TB; Chen Z
    World J Gastroenterol; 2020 May; 26(20):2559-2569. PubMed ID: 32523311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet.
    Mahana D; Trent CM; Kurtz ZD; Bokulich NA; Battaglia T; Chung J; Müller CL; Li H; Bonneau RA; Blaser MJ
    Genome Med; 2016 Apr; 8(1):48. PubMed ID: 27124954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin A and liver diseases.
    Inamine T; Schnabl B
    J Gastroenterol; 2018 Jun; 53(6):691-700. PubMed ID: 29075899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut-liver axis and the intersection with the microbiome.
    Tripathi A; Debelius J; Brenner DA; Karin M; Loomba R; Schnabl B; Knight R
    Nat Rev Gastroenterol Hepatol; 2018 Jul; 15(7):397-411. PubMed ID: 29748586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiota and the Hepatologist: Will Our Bugs Prove to be the Missing Link?
    Pallen MJ; Quraishi MN
    Dig Dis; 2017; 35(4):377-383. PubMed ID: 28468018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target].
    Ciocan D; Cassard AM
    Med Sci (Paris); 2020 Apr; 36(4):310-312. PubMed ID: 32356701
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of gut microbiota in intestinal and liver diseases.
    Hrncir T; Hrncirova L; Kverka M; Tlaskalova-Hogenova H
    Lab Anim; 2019 Jun; 53(3):271-280. PubMed ID: 30580671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enteric microbiome in hepatobiliary health and disease.
    Tabibian JH; Varghese C; LaRusso NF; O'Hara SP
    Liver Int; 2016 Apr; 36(4):480-7. PubMed ID: 26561779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.